2432932
Project Grant
Overview
Grant Description
Sttr Phase I: Wafer-scale, foundry-ready TI:Sapphire integrated photonic lasers and amplifiers.
The broader impact/commercial impacts of this Small Business Technology Transfer (STTR) Phase I project is in development of compact, portable, and affordable devices for biomedical imaging.
The advanced imaging instruments could be used in diverse fields and applications, ranging from neuroscience research to early cancer detection at the point of care.
By developing a photonic platform that can produce these devices at scale, this project aims to make these instruments affordable enough to be widely used in physicians' offices, dramatically improving access to critical diagnostic technologies.
This project's technical innovations will be in reducing the cost and complexity of lasers operating in the visible and near-infrared wavelength spectrum, which are vital in emerging fields like quantum computing.
Such an advancement in integrated photonics would also result in more compact and cost-efficient atomic optical clocks, which are essential for defense navigation systems.
These societally important applications will generate initial revenue to fund the development of low-cost, two-photon microscopes for cancer detection, reducing the timescale necessary for lifesaving decisions while creating a durable competitive advantage within the cancer diagnostics market.
This Small Business Technology Transfer (STTR) Phase I project aims to transition the TI:Sapphire-on-Insulator (TI:SAOI) platform from an academic demonstration to a wafer-scale, CMOS-foundry compatible process.
This project will enable the scalable production of integrated TI:Sapphire lasers and amplifiers in the wavelength range of 700 – 1000 nm, revolutionizing the high-performance visible and near-infrared laser market.
Previous proof-of-concept devices had limited performance due to nascent fabrication technology with high propagation losses and were built using chip-scale techniques that could not be scaled for direct commercial viability.
This effort lays the foundation for wafer-scale production of this technology, by developing efficient methods of doping sapphire, optimizing plasma etching, and producing a narrow-linewidth laser with the efficiency and power capable of addressing market needs.
These advances in the TI:SAOI platform will then enable the realization of transformative on-chip mode-locked laser technology at scale.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.
Subawards are planned for this award.
The broader impact/commercial impacts of this Small Business Technology Transfer (STTR) Phase I project is in development of compact, portable, and affordable devices for biomedical imaging.
The advanced imaging instruments could be used in diverse fields and applications, ranging from neuroscience research to early cancer detection at the point of care.
By developing a photonic platform that can produce these devices at scale, this project aims to make these instruments affordable enough to be widely used in physicians' offices, dramatically improving access to critical diagnostic technologies.
This project's technical innovations will be in reducing the cost and complexity of lasers operating in the visible and near-infrared wavelength spectrum, which are vital in emerging fields like quantum computing.
Such an advancement in integrated photonics would also result in more compact and cost-efficient atomic optical clocks, which are essential for defense navigation systems.
These societally important applications will generate initial revenue to fund the development of low-cost, two-photon microscopes for cancer detection, reducing the timescale necessary for lifesaving decisions while creating a durable competitive advantage within the cancer diagnostics market.
This Small Business Technology Transfer (STTR) Phase I project aims to transition the TI:Sapphire-on-Insulator (TI:SAOI) platform from an academic demonstration to a wafer-scale, CMOS-foundry compatible process.
This project will enable the scalable production of integrated TI:Sapphire lasers and amplifiers in the wavelength range of 700 – 1000 nm, revolutionizing the high-performance visible and near-infrared laser market.
Previous proof-of-concept devices had limited performance due to nascent fabrication technology with high propagation losses and were built using chip-scale techniques that could not be scaled for direct commercial viability.
This effort lays the foundation for wafer-scale production of this technology, by developing efficient methods of doping sapphire, optimizing plasma etching, and producing a narrow-linewidth laser with the efficiency and power capable of addressing market needs.
These advances in the TI:SAOI platform will then enable the realization of transformative on-chip mode-locked laser technology at scale.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.
Subawards are planned for this award.
Awardee
Funding Goals
THE GOAL OF THIS FUNDING OPPORTUNITY, "NSF SMALL BUSINESS INNOVATION RESEARCH (SBIR)/ SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAMS PHASE I", IS IDENTIFIED IN THE LINK: HTTPS://WWW.NSF.GOV/PUBLICATIONS/PUB_SUMM.JSP?ODS_KEY=NSF23515
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Sugar Land,
Texas
77479-3520
United States
Geographic Scope
Single Zip Code
Brightlight Photonics was awarded
Project Grant 2432932
worth $275,000
from National Science Foundation in February 2025 with work to be completed primarily in Sugar Land Texas United States.
The grant
has a duration of 8 months and
was awarded through assistance program 47.084 NSF Technology, Innovation, and Partnerships.
The Project Grant was awarded through grant opportunity NSF Small Business Innovation Research / Small Business Technology Transfer Phase I Programs.
SBIR Details
Research Type
STTR Phase I
Title
STTR Phase I: Wafer-scale, foundry-ready Ti:Sapphire integrated photonic lasers and amplifiers
Abstract
The broader impact/commercial impacts of this Small Business Technology Transfer (STTR) Phase I project is in development of compact, portable, and affordable devices for biomedical imaging. The advanced imaging instruments could be used in diverse fields and applications, ranging from neuroscience research to early cancer detection at the point of care. By developing a photonic platform that can produce these devices at scale, this project aims to make these instruments affordable enough to be widely used in physicians’ offices, dramatically improving access to critical diagnostic technologies. This project’s technical innovations will be in reducing the cost and complexity of lasers operating in the visible and near-infrared wavelength spectrum, which are vital in emerging fields like quantum computing. Such an advancement in integrated photonics would also result in more compact and cost-efficient atomic optical clocks, which are essential for defense navigation systems. These societally important applications will generate initial revenue to fund the development of low-cost, two-photon microscopes for cancer detection, reducing the timescale necessary for lifesaving decisions while creating a durable competitive advantage within the cancer diagnostics market.
This Small Business Technology Transfer (STTR) Phase I project aims to transition the Ti:Sapphire-on-insulator (Ti:SaOI) platform from an academic demonstration to a wafer-scale, CMOS-foundry compatible process. This project will enable the scalable production of integrated Ti:Sapphire lasers and amplifiers in the wavelength range of 700 – 1000 nm, revolutionizing the high-performance visible and near-infrared laser market. Previous proof-of-concept devices had limited performance due to nascent fabrication technology with high propagation losses and were built using chip-scale techniques that could not be scaled for direct commercial viability. This effort lays the foundation for wafer-scale producti
Topic Code
PH
Solicitation Number
NSF 23-515
Status
(Ongoing)
Last Modified 1/14/25
Period of Performance
2/15/25
Start Date
10/31/25
End Date
Funding Split
$275.0K
Federal Obligation
$0.0
Non-Federal Obligation
$275.0K
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
2432932
SAI Number
None
Award ID URI
SAI EXEMPT
Awardee Classifications
Small Business
Awarding Office
491503 TRANSLATIONAL IMPACTS
Funding Office
491503 TRANSLATIONAL IMPACTS
Awardee UEI
ZPD5X7DEX9N1
Awardee CAGE
9U0R5
Performance District
TX-22
Senators
John Cornyn
Ted Cruz
Ted Cruz
Modified: 1/14/25